Effect of the somatotropic hormone, insulin and durabolin on postadjuvant polyarthritis in rats.
D000276:Adjuvants, Immunologic; D000818:Animals; D001168:Arthritis / Q000209:etiology / Q000276:immunology* / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007328:Insulin / Q000494:pharmacology*; D049528:Insulin, Long-Acting / Q000008:administration & dosage; D008214:Lymphocytes / Q000187:drug effects; D009277:Nandrolone / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007328:Insulin; D049528:Insulin, Long-Acting; D009277:Nandrolone; D013006:Growth Hormone